Invenomic Capital Management’s WEX WEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-50,683
Closed -$7.44M 183
2025
Q2
$7.44M Sell
50,683
-9,941
-16% -$1.34M 0.42% 75
2025
Q1
$9.52M Sell
60,624
-34,499
-36% -$5.68M 0.48% 75
2024
Q4
$16.7M Buy
+95,123
New +$17.8M 0.79% 36
2024
Q2
Sell
-96,966
Closed -$23M 187
2024
Q1
$23M Sell
96,966
-100,885
-51% -$21.7M 1.23% 28
2023
Q4
$38.5M Sell
197,851
-87,672
-31% -$15.9M 1.76% 14
2023
Q3
$53.7M Sell
285,523
-7,798
-3% -$1.51M 2.26% 6
2023
Q2
$53.4M Buy
293,321
+92,574
+46% +$16.4M 2.71% 5
2023
Q1
$36.9M Buy
200,747
+97,838
+95% +$17.8M 2.09% 12
2022
Q4
$16.8M Sell
102,909
-5,575
-5% -$868K 1.14% 24
2022
Q3
$13.8M Buy
+108,484
New +$17.1M 1.18% 28

Other funds holding WEX

Invenomic Capital Management's WEX Position: Q3 2025 in Review

Invenomic Capital Management sold out of WEX (WEX) in Q3 2025, closing a stake of 50,683 shares — an estimated $7.44M sold.

Invenomic Capital Management first reported a position in WEX in Q3 2022 and held it in 10 quarters. The position peaked at $53.7M in Q3 2023. 391 funds tracked by Wall St. Rank hold WEX as of Q3 2025.

  • Invenomic Capital Management reported no remaining WEX position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 50,683 WEX shares in Q3 2025, an estimated $7.44M.
  • Invenomic Capital Management first reported a position in WEX in Q3 2022 and held it in 10 quarters.
  • Invenomic Capital Management's WEX position peaked at $53.7M in Q3 2023.
  • 391 funds tracked by Wall St. Rank held WEX as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.